Condition: Aortic Valve Stenosis and Insufficiency · Sponsor: Xijing Hospital
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.
This description comes directly from the study's public registry record.
Rutao Wang, M.D, Ph.D · +86-15091095796 · rutaowang@qq.com
Always discuss trial participation with your own doctor first.
| Xijing Hospital | Xi'an, Shannxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06379386